Skip to main content
SpringerLink
Log in

Overcoming some Limiting Factors in Tumour Immunotherapy

  • Original Article
  • Published:
British Journal of Cancer Submit manuscript

Abstract

Immunotherapy using rat 7s antibodies against plasmacytoma 5563 in C3H mice has been measured carefully. Prior adsorption of antibodies with normal mouse tissues, and supplements of co-optable non-immunized macrophages and lymphocytes enhanced the scope of immunotherapy against established tumours. It is suggested that available co-optable lymphocytes and macrophages are imporant limiting factors in tumour immunotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Authors
  1. O Fakhri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J R Hobbs
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fakhri, O., Hobbs, J. Overcoming some Limiting Factors in Tumour Immunotherapy. Br J Cancer 28, 1–5 (1973). https://doi.org/10.1038/bjc.1973.64

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1973.64

  • Springer Nature Limited

Search

Navigation